Carbonic anhydrase XII inhibition overcomes P-glycoprotein-mediated drug resistance: a potential new combination therapy in cancer

Abstract

Intrinsic or acquired resistance to chemotherapy is a major hurdle in the treatment of cancer. One of the key mechanisms of resistance is the overexpression of the drug efflux transporter P-glycoprotein (Pgp). Pgp overexpression renders a large number of mechanistically unrelated chemotherapies ineffective. Targeting Pgp inhibition directly to overcome drug resistance, although conceptually and mechanistically attractive, has not translated to the clinic, in part because Pgp also has a critical protective function in many healthy tissues. It was recently discovered that carbonic anhydrase XII (CA XII), an enzyme associated with pH regulation in cancer, is co-expressed and co-located with Pgp in drug resistant cancer cells. CA XII is also upregulated by hypoxia, which is another microenvironmental factor that contributes to drug resistance. Here, we review findings that demonstrate modulation of CA XII may offer a promising new approach towards overcoming the longstanding hurdle of drug resistance and therapy failure against solid cancers. This review covers the use of CA XII inhibitors, both small molecule and antibody, in combination with chemotherapeutics that are substrates for Pgp. This combination therapy approach restores the efficacy of chemotherapy in resistant cells and offers a potential new therapeutic window to re-examine the targeting of Pgp as a safe, effective, and novel anticancer strategy.

Keywords

Carbonic anhydrase XII / P-glycoprotein / drug resistance / tumor microenvironment / pH / hypoxia / inhibitor / chemotherapy

References

[1] Gwangwa MV,Visagie MH.Crosstalk between the Warburg effect, redox regulation and autophagy induction in tumourigenesis..Cell Mol Biol Lett2018;23:20 PMCID:PMC5935986

[2] Corbet C.Tumour acidosis: from the passenger to the driver’s seat..Nat Rev Oncol2017;17:577-93

[3] Gottesman MM,Bates SE.Multidrug resistance in cancer: role of ATP-dependent transporters..Nat Rev Cancer2002;2:48-58

[4] Eckford PD.ABC efflux pump-based resistance to chemotherapy drugs..Chem Rev2009;109:2989-3011

[5] Marine JC,Dawson MA.Non-genetic mechanisms of therapeutic resistance in cancer..Nat Rev Cancer2020;20:743-56

[6] Zahreddine H.Mechanisms and insights into drug resistance in cancer..Front Pharmacol2013;4:28 PMCID:PMC3596793

[7] Dean M,Bates S.Tumour stem cells and drug resistance..Nat Rev Cancer2005;5:275-84

[8] Hirschmann-Jax C,Wulf GG.A distinct “side population” of cells with high drug efflux capacity in human tumor cells..Proc Natl Acad Sci U S A2004;101:14228-33 PMCID:PMC521140

[9] Breier A,Seres M,Sulova Z.New insight into P-glycoprotein as a drug target..Anticancer Agents Med Chem2013;13:159-70

[10] Robey RW,Hall MD,Bates SE.Revisiting the role of ABC transporters in multidrug-resistant cancer..Nat Rev Cancer2018;18:452-64 PMCID:PMC6622180

[11] Xia D,Esser L.Emerging consensus on the mechanism of polyspecific substrate recognition by the multidrug transporter P-glycoprotein..Cancer Drug Resist2019;2:471-89

[12] Grandane A,Zalubovskis R.6-Triazolyl-substituted sulfocoumarins are potent, selective inhibitors of the tumor-associated carbonic anhydrases IX and XII..Bioorg Med Chem Lett2014;24:1256-60

[13] Amin ML.P-glycoprotein inhibition for optimal drug delivery..Drug Target Insights2013;7:27-34 PMCID:PMC3762612

[14] Kopecka J,Jacobs A.Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells..Oncotarget2015;6:6776-93 PMCID:PMC4466649

[15] Alterio V,D’Ambrosio K,De Simone G.Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?.Chem Rev2012;112:4421-68

[16] Wykoff CC,Watson PH.Hypoxia-inducible expression of tumor-associated carbonic anhydrases..Cancer Res2000;60:7075-83

[17] Waheed A.Carbonic anhydrase XII functions in health and disease..Gene2017;623:33-40 PMCID:PMC5851007

[18] Mboge MY,McKenna R.Carbonic anhydrases: role in pH control and cancer..Metabolites2018;8:19 PMCID:PMC5876008

[19] Chiche J,Pouysségur J.Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer..J Cell Mol Med2010;14:771-94 PMCID:PMC3823111

[20] Stubbs M,Griffiths JR.Causes and consequences of tumour acidity and implications for treatment..Molecular Medicine Today2000;6:15-9

[21] Chiche J,Laferrière J.Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH..Cancer Res2009;69:358-68

[22] Swietach P,Cobden P,Harris AL.Tumor-associated carbonic anhydrase 9 spatially coordinates intracellular pH in three-dimensional multicellular growths..J Biol Chem2008;283:20473-83

[23] Neri D.Interfering with pH regulation in tumours as a therapeutic strategy..Nat Rev Drug Discov2011;10:767-77

[24] Türeci O,Vollmar E.Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers..Proc Natl Acad Sci U S A1998;95:7608-13 PMCID:PMC22698

[25] Whittington DA,Ulmasov B.Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells..Proc Natl Acad Sci U S A2001;98:9545-50 PMCID:PMC55489

[26] Sahin U,Schmitt H.Human neoplasms elicit multiple specific immune responses in the autologous host..Proc Natl Acad Sci U S A1995;92:11810-3 PMCID:PMC40492

[27] Ashida S,Tanimura M,Shuin T.Effects of von Hippel-Lindau gene mutation and methylation status on expression of transmembrane carbonic anhydrases in renal cell carcinoma..J Cancer Res Clin Oncol2002;128:561-8

[28] Ohh M,Ivan M.Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein..Nat Cell Biol2000;2:423-7

[29] Ivanov S,Ivanova A.Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer..Am J Pathol2001;158:905-19 PMCID:PMC1850340

[30] Wykoff CC,Watson PH.Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast..Am J Pathol2001;158:1011-9 PMCID:PMC1850356

[31] Kivelä A,Saarnio J.Expression of a novel transmembrane carbonic anhydrase isozyme XII in normal human gut and colorectal tumors..Am J Pathol2000;156:577-84 PMCID:PMC1850052

[32] Barnett DH,Charn TH.Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer..Cancer Res2008;68:3505-15

[33] Hynninen P,Saarnio J.Expression of transmembrane carbonic anhydrases IX and XII in ovarian tumours..Histopathology2006;49:594-602

[34] Ilie MI,Ortholan C.Overexpression of carbonic anhydrase XII in tissues from resectable non-small cell lung cancers is a biomarker of good prognosis..Int J Cancer2011;128:1614-23

[35] Proescholdt MA,Kubitza M.Expression of hypoxia-inducible carbonic anhydrases in brain tumors..Neuro Oncol2005;7:465-75 PMCID:PMC1871734

[36] Parkkila S,Saarnio J.Expression of the membrane-associated carbonic anhydrase isozyme XII in the human kidney and renal tumors..J Histochem Cytochem2000;48:1601-8

[37] Leppilampi M,Karttunen TJ.Carbonic anhydrase isozymes IX and XII in gastric tumors..World J Gastroenterol2003;9:1398-403 PMCID:PMC4615471

[38] Haapasalo J,Haapasalo H.The expression of carbonic anhydrases II, IX and XII in brain tumors..Cancers2020;12:1723 PMCID:PMC7408524

[39] Saarnio J,Parkkila AK.Immunohistochemistry of carbonic anhydrase isozyme IX (MN/CA IX) in human gut reveals polarized expression in the epithelial cells with the highest proliferative capacity..J Histochem Cytochem1998;46:497-504

[40] Pastoreková S,Parkkila AK.Carbonic anhydrase IX, MN/CA IX: analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts..Gastroenterology1997;112:398-408

[41] Hsieh MJ,Chiou HL.Carbonic anhydrase XII promotes invasion and migration ability of MDA-MB-231 breast cancer cells through the p38 MAPK signaling pathway..Eur J Cell Biol2010;89:598-606

[42] Vergara D,Fonzi E.Carbonic Anhydrase XII Expression Is Modulated during epithelial mesenchymal transition and regulated through protein kinase C signaling..Int J Mol Sci2020;21:715 PMCID:PMC7037142

[43] Chen Z,Mboge MY.Differential expression and function of CAIX and CAXII in breast cancer: A comparison between tumorgraft models and cells..PLoS One2018;13:e0199476 PMCID:PMC6028082

[44] Kopecka J,Salaroglio IC,Riganti C.P-glycoprotein-mediated chemoresistance is reversed by carbonic anhydrase XII inhibitors..Oncotarget2016;7:85861-75 PMCID:PMC5349880

[45] Mujumdar P,Bua S,Riganti C.Carbonic anhydrase XII inhibitors overcome temozolomide resistance in glioblastoma..J Med Chem2019;62:4174-92

[46] Salaroglio IC,Annovazzi L.Carbonic anhydrase XII inhibitors overcome p-glycoprotein-mediated resistance to temozolomide in glioblastoma..Mol Cancer Ther2018;17:2598-609

[47] Oksala N,Pelto-Huikko M.Carbonic anhydrases II and XII are up-regulated in osteoclast-like cells in advanced human atherosclerotic plaques-Tampere Vascular Study..Ann Med2010;42:360-70

[48] Liao SY,Ivanova A.Expression of cell surface transmembrane carbonic anhydrase genes CA9 and CA12 in the human eye: overexpression of CA12 (CAXII) in glaucoma..J Med Genet2003;40:257-61 PMCID:PMC1735430

[49] Van Berkel MA.Evaluating off-label uses of acetazolamide..Am J Health Syst Pharm2018;75:524-31

[50] Supuran CT.Carbonic anhydrases: novel therapeutic applications for inhibitors and activators..Nat Rev Drug Discov2008;7:168-81

[51] Lopez M,Supuran CT.Carbonic anhydrase inhibitors developed through ‘click tailing’..Curr Pharm Des2010;16:3277-87

[52] Vullo D,Nishimori I.Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs?.Bioorg Med Chem Lett2005;15:963-9

[53] Wilkinson BL,Houston TA,Supuran CT.A novel class of carbonic anhydrase inhibitors: glycoconjugate benzene sulfonamides prepared by “click-tailing”..J Med Chem2006;49:6539-48

[54] Scozzafava A,Mincione F,Mincione G.Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring?.J Med Chem1999;42:2641-50

[55] Tanpure RP,Peat TS.Carbonic anhydrase inhibitors with dual-tail moieties to match the hydrophobic and hydrophilic halves of the carbonic anhydrase active site..J Med Chem2015;58:1494-501

[56] Battke C,Mysliwietz J.Generation and characterization of the first inhibitory antibody targeting tumour-associated carbonic anhydrase XII..Cancer Immunol Immunother2011;60:649-58

[57] Jensen RL.Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target..J Neurooncol2009;92:317-35

[58] Gondi G,Hulikova A.Antitumor efficacy of a monoclonal antibody that inhibits the activity of cancer-associated carbonic anhydrase XII..Cancer Res2013;73:6494-503

[59] Alterio V,Esposito D.Biochemical and structural insights into carbonic anhydrase XII/Fab6A10 complex..J Mol Biol2019;431:4910-21

[60] Moon YR.Antibody binding to carbonic anhydrase and use thereof. In: Office USPaT, editor.2019;United StatesAprogen Kic Inc.

[61] Webb BA,Jacobson MP.Dysregulated pH: a perfect storm for cancer progression..Nat Rev Cancer2011;11:671-7

[62] Damaghi M.Phenotypic changes of acid-adapted cancer cells push them toward aggressiveness in their evolution in the tumor microenvironment..Cell Cycle2017;16:1739-43 PMCID:PMC5628657

[63] Pillai SR,Marunaka Y,Fais S.Causes, consequences, and therapy of tumors acidosis..Cancer Metastasis Rev2019;38:205-22 PMCID:PMC6625890

[64] Andreucci E,Ruzzolini J.The acidic tumor microenvironment drives a stem-like phenotype in melanoma cells..J Mol Med2020;98:1431-46 PMCID:PMC7525286

[65] Ledaki I,Wigfield S.Carbonic anhydrase IX induction defines a heterogeneous cancer cell response to hypoxia and mediates stem cell-like properties and sensitivity to HDAC inhibition..Oncotarget2015;6:19413-27 PMCID:PMC4637295

[66] Boedtkjer E.The acidic tumor microenvironment as a driver of cancer..Annu Rev Physiol2020;82:103-26

[67] Morris JC,Grellier C.Targeting hypoxic tumor cell viability with carbohydrate-based carbonic anhydrase IX and XII inhibitors..J Med Chem2011;54:6905-18

[68] Moeker J,Bornaghi LF.Structural insights into carbonic anhydrase IX isoform specificity of carbohydrate-based sulfamates..J Med Chem2014;57:8635-45 PMCID:PMC4207533

[69] Podolski-Renić A,Stanković T.Sulfocoumarins, specific carbonic anhydrase IX and XII inhibitors, interact with cancer multidrug resistant phenotype through pH regulation and reverse P-glycoprotein mediated resistance..Eur J Pharm Sci2019;138:105012

[70] Maresca A,Vu H.Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors..J Am Chem Soc2009;131:3057-62

[71] Waldman AJ,Peng W.Heteroatom-heteroatom bond formation in natural product biosynthesis..Chemical Reviews2017;117:5784-863 PMCID:PMC5534343

[72] Mujumdar P.Natural product primary sulfonamides and primary sulfamates..J Nat Prod2015;78:1470-7

[73] Mujumdar P,Supuran CT,Poulsen SA.Synthesis, structure and bioactivity of primary sulfamate-containing natural products..Bioorg Med Chem Lett2018;28:3009-13

[74] Mujumdar P,Tonissen KF.An unusual natural product primary sulfonamide: synthesis, carbonic anhydrase inhibition, and protein x-ray structures of psammaplin C..J Med Chem2016;59:5462-70

[75] Auffinger B,Pytel P,Lesniak MS.The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence..Expert Rev Neurother2015;15:741-52 PMCID:PMC4830899

[76] Carvalho BF,Almeida DS.Second-line chemotherapy in recurrent glioblastoma: A 2-cohort gtudy..Oncol Res Treat2015;38:348-54

[77] von Neubeck B,Riganti C.An inhibitory antibody targeting carbonic anhydrase XII abrogates chemoresistance and significantly reduces lung metastases in an orthotopic breast cancer model in vivo..Int J Cancer2018;143:2065-75

[78] Thurber GM,Wittrup KD.Antibody tumor penetration: transport opposed by systemic and antigen-mediated clearance..Adv Drug Deliv Rev2008;60:1421-34 PMCID:PMC2820307

[79] Cruz E.Monoclonal antibody therapy of solid tumors: clinical limitations and novel strategies to enhance treatment efficacy..Biologics2019;13:33-51 PMCID:PMC6503308